Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oligonucleotide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced nanofiltration technology purifies oligonucleotide synthons enhancing supply chain reliability and reducing manufacturing costs for pharmaceutical intermediates globally.
Patent CN118955591B discloses novel nucleoside monomers reducing off-target effects. Enhance supply chain reliability and cost efficiency in oligonucleotide manufacturing.
Patent CN107556355A reveals novel AcO-MMT-Cl route for high-purity nucleoside phosphoramidites. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN1409719A details a stepwise sulfur transfer process for high-purity oligonucleotides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel chlorination-coupling method for alpha nucleosides. Reduces purification steps, improves selectivity for antisense drug manufacturing.
Patent CN107056590B details a safe industrial method for 4,4'-dimethoxytriphenylchloromethane, offering cost reduction and high purity for nucleoside manufacturing.
Novel C-P bond modification strategy enhances siRNA stability and Ago2 affinity. Reliable supplier for complex oligonucleotide intermediates with scalable solid-phase synthesis.
Patent CN121248673A details (2S)-UNA monomer synthesis enabling 5-prime to 3-prime oligonucleotide assembly with enhanced stability and supply chain reliability.
Novel patent CN115181147B enables high-purity nucleoside intermediates with streamlined synthesis for cost-effective pharmaceutical manufacturing supply chains.
Patent CN104211741B reveals a scalable synthesis method for deuterated thymidine phosphoramidites, offering high purity and cost-effective manufacturing solutions for global research.
Patent CN108738321B details novel GalNAc phosphoramidites for oligonucleotide conjugates, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN110590886B details a novel 6'-nitrile LNA synthesis enhancing nuclease resistance. Discover scalable routes for high-affinity oligonucleotide intermediates.
Patent CN107556355B discloses a novel synthesis route for high-purity nucleoside diphosphite amides, enabling superior quality control in antisense drug manufacturing.
Novel cesium carbonate catalyzed process for high-purity nucleoside modifiers. Reduces cost and improves supply chain reliability for antisense drug manufacturing.
Novel scalable route for antisense oligonucleotide intermediates ensuring high purity and cost reduction without preparative chromatography.
Novel enzymatic route for 2'-O-propynyl-guanosine. Higher yield, simplified process for oligonucleotide manufacturing supply chain.
Patent CN1380299A reveals a crystallization method replacing column chromatography for purifying nucleoside intermediates, offering significant cost and scalability advantages.
Patent CN118852303A details a novel aminolysis method for cytidine vinyl phosphate, offering high purity and cost reduction in nucleoside manufacturing for global supply chains.
Patent CN116444589B reveals liquid phase coupling boosting yield over 10 times solid phase methods for high-purity pharmaceutical intermediates.
Patent CN116444589B reveals high-yield liquid phase synthesis for GalNAc conjugates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates significantly.